Cantel Medical (CMD) Tops Q4 EPS by 1c

Cantel Medical (NYSE: CMD) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $228.9 million versus the consensus estimate of $225.98 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance